AlphaSolid® is a tissue biopsy test designed for patients with advanced solid cancers. Our patented UniqSeqⓇ technology detects tumor DNA for comprehensive genomic analysis.
AlphaSolid® detects the four classes of variations (SNV, INDEL, fusion, and CNV) and the two genomic signatures of immunotherapy (MSI and TMB) in 118 NCCN-recommended genes associated with major cancer types. With this data, IMB Dx can provide information on appropriate therapy options and related on-going clinical trials.